Vol. 30.S2 September 2025 | Annals of Hepatology

DRUG-INDUCED DUCTOPENIA IN THE SPANISH AND LATINDILI REGISTRIES

Fernando Bessone, Nelia Hernandez, Maria Isabel Schinoni, Javier Brahm, Inmaculada Medina-Caliz, Daniela Chiodi, Mercedes Robles-Díaz, Ismael Alvarez-Alvarez, ... Raul Jesus Andrade

Ann Hepatol. 2025;30 Supl 2:101948

Full text access

Share

VALIDATION OF NONINVASIVE CLINICAL PATHWAYS TO IDENTIFY ADVANCED

Luis Antonio Díaz Piga, Natalia Baeza, Francisco Idalsoaga, Xiao-Dong Zhou, Ming-Hua Zheng, Fátima Higuera de la Tijera, Fernando Javier Barreyro, Rakhi Maiwall, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:101949

Full text access

Share

CHOLANGIOCARCINOMA IN INDIVIDUALS WITH CHRONIC LIVER DISEASE IS DIAGNOSED EARLIER, LEADING TO BETTER PROGNOSIS

Laura Izquierdo Sanchez, Julen Matin Robles, Jone Narbaiza, Angela Lamarca, Adelaida La Casta, Heinz-Josef Klümpen, Arun Valsan, Stephanie Roessler, ... Jesus M. Banales

Ann Hepatol. 2025;30 Supl 2:101950

Full text access

Share

PERFORMANCE OF NON-INVASIVE TESTS (NITS) AND PREDICTORS OF OUTCOMES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) FROM LATIN AMERICA AND NORTH AMERICA

Zobair Younossi, Leyla de Avila, Claudia P. Oliveira, Cristiane Villela-Nogueira, Marlen Ivon Castellanos Fernandez, Adrian Carlos Gadano, Marco Antonio Arrese Jimenez, Naim Alkhouri, ... Mário Guimaraes Pessôa

Ann Hepatol. 2025;30 Supl 2:101951

Full text access

Share

ACCELERATED PROGRESSION TO CIRRHOSIS AND HEPATIC DECOMPENSATION IN METALD AND ALD COMPARED TO MASLD: A GLOBAL STUDY

Luis Antonio Díaz Piga, Xiao-Dong Zhou, Natalia Baeza, Francisco Idalsoaga, Gustavo Ayares, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:101952

Full text access

Share

FACTORS ASSOCIATED WITH HEALTH LITERACY IN PATIENTS DIAGNOSED WITH LIVER CIRRHOSIS IN COLOMBIA

Ismael de Jesus Yepes Barreto, Carlos Martelo, Nicole Chamorro

Ann Hepatol. 2025;30 Supl 2:101953

Full text access

Share

MELD 3.0 PERFORMANCE: EXTERNAL VALIDATION IN A LATIN AMERICAN TRANSPLANT LIVER COHORT

Josefina Pages Maronese, Federico Piñero, Graciela Castro Narro, Yahvé Iván López Méndez, Ignacio Roca, Nicolas Dominguez, Fernando Cairo, Angelo Z. Mattos, ... Manuel Mendizabal

Ann Hepatol. 2025;30 Supl 2:101954

Full text access

Share

HEPATITIS C SCREENING AND GENDER DISPARITIES IN POSITIVITY RATES IN ARGENTINA

Manuel Barbero, Ignacio Roca, Nicolas Dominguez, Lucia Navarro, Omar Galdame, Fernando Cairo

Ann Hepatol. 2025;30 Supl 2:101955

Full text access

Share

TEMPORAL TRENDS IN CHARACTERISTICS AND OUTCOMES OF SIMULTANEOUS LIVER–KIDNEY TRANSPLANT RECIPIENTS IN LATIN AMERICA FROM 2003 TO 2025

Jorge Carlos Martinez Morales, Valeria Descalzi, Adrián Gadano, Graciela Elia Castro Narro, Mario Vilatobá, Alina Zerega, Fernando Cairo, Manuel Mendizabal, ... Sebastián Marciano

Ann Hepatol. 2025;30 Supl 2:101956

Full text access

Share

EVIDENCE-BASED DIGITAL SUPPORT IN HEPATOLOGY: RETRIEVAL-AUGMENTED GENERATION'S ROLE IN AUTOIMMUNE LIVER DISEASES MANAGEMENT

Ezequiel Ridruejo, Ernesto Saenz, Jimmy Daza, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bommel, Andreas Geier, ... Andreas Teufel

Ann Hepatol. 2025;30 Supl 2:101957

Full text access

Share

EFFECTIVE RE-ENGAGEMENT OF HEPATITIS C PATIENTS: A MULTICENTER STUDY BASED ON LABORATORY RECORDS IN ARGENTINA

Fernando Cairo, Manuel Barbero, Nicolas Dominguez, Stefania Burgos, Lucia Navarro, Ignacio Roca, Adrian Bologna, Daniel Calfunao, ... Esteban Gonzalez Ballerga

Ann Hepatol. 2025;30 Supl 2:101958

Full text access

Share

LATIN AMERICAN SURVEILLANCE REGISTRY REVEALS HIGHER ANTIMICROBIAL RESISTANCE IN INVASIVE ISOLATES FROM PATIENTS WITH CIRRHOSIS COMPARED TO EUROPEAN BENCHMARKS

Gonzalo Gomez Perdiguero, Maria Dolores Murga, Ana Palazzo, Esteban Gonzalez Ballerga, Ilse Pardo Ivirico, Maria Daniela Perez, Lorena Notari, Josefina Pages, ... Sebastian Marciano

Ann Hepatol. 2025;30 Supl 2:101959

Full text access

Share

BRIDGING THE GAP IN HCC CARE: FIRST REAL-WORLD ANALYSIS OF BCLC ADHERENCE AND SURVIVAL IN A CENTRAL AMERICAN POPULATION

Wagner Ramirez Quesada, María Fernanda Lynch Mejía, Francisco Vargas Navarro, María José Soto Echeverri, Fiorella Ajún, Alejandra Ochoa Palominos, Pablo Coste

Ann Hepatol. 2025;30 Supl 2:101960

Full text access

Share

ABO - INCOMPATIBLE LIVER TRANSPLANTATION FROM DECEASED DONORS: A PROMISING ALTERNATIVE FOR LATIN AMERICA IN LOW ORGAN DONATION SCENARIOS

María Fernanda Lynch Mejía, Wagner Ramírez Quesada, Francisco Vargas Navarro, Sheila Araya Chavarría, Alejandra Ochoa Palominos, Pablo Coste Murillo

Ann Hepatol. 2025;30 Supl 2:101961

Full text access

Share

TRANSFORMING OUTPATIENT HEPATIC CARE IN LATIN AMERICA: A SCALABLE, NURSE-DRIVEN APPROACH

Francisco Vargas-Navarro, Maria Soto-Echeverri, Daniel Mondragón-Bustos, Wagner Ramírez-Quesada, Maria Lynch-Mejía, Roy Quesada-Mora, Alejandra Ochoa-Palominos, Pablo Coste

Ann Hepatol. 2025;30 Supl 2:101962

Full text access

Share

CRITICAL MEDIATORS OF INFLAMMATION-DRIVEN HEPATOCARCINOGENESIS INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

Linda Vanessa Márquez Quiroga, Eduardo E. Vargas Pozada, Irina Cardoso Lezama, Carolina Piña Vázquez, Jaime Arellanes Robledo, Pablo Muriel de la Torre

Ann Hepatol. 2025;30 Supl 2:101963

Full text access

Share

EARLY IDENTIFICATION OF LIVER TRANSPLANTATION REQUIREMENT IN ALCOHOL-ASSOCIATED HEPATITIS

Luis Antonio Díaz Piga, Francisco Idalsoaga, Gene Im, Bastián Alcayaga, Muzzafar Haque, Stephanie Rutledge, Hanna Blaney, Pojsakorn Danpanichkul, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:101964

Full text access

Share

LONG-TERM ALBUMIN THERAPY MAY IMPROVE SURVIVAL IN CIRRHOSIS WITH ASCITES: A SYSTEMATIC REVIEW AND META-ANALYSIS

W. Ray Kim, Guadalupe Garcia-Tsao, Cristina Coll-Ortega, Elisabet Viayna, Thomas Ardiles, Rahul Rajkumar

Ann Hepatol. 2025;30 Supl 2:101965

Full text access

Share

LIVER FIBROSIS IN INDIVIDUALS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN LATIN AMERICA: INTERIM RESULTS FROM THE STELLA STUDY

Luis Antonio Díaz Piga, Francisco Idalsoaga, Mario G. Pessoa, Claudia Pinto Marques Souza de Oliveira, Patricia Zitelli, Ezequiel Ridruejo, Mirta Peralta, Cesar Castro, ... Marco Arrese

Ann Hepatol. 2025;30 Supl 2:101966

Full text access

Share

SOCIAL AND HEALTH VULNERABILITY ANALYSIS AMONG PEOPLE WHO INJECT DRUGS IN ARMENIA, COLOMBIA

Javier Enrique Hernandez Blanco, Juan Ignacio Marin Zuluaga, Ismael de Jesús Yepes Barreto, Diana Chávez Bejarano, Alfredo Spath, Sara Milena Ramos Jaraba, Dedsy Yajaira Berbesí Fernández

Ann Hepatol. 2025;30 Supl 2:101967

Full text access

Share

REVIRAL: ROADMAP FOR THE ELIMINATION OF VIRAL HEPATITIS IN LATIN AMERICA

Javier Crespo, Joaquin Cabezas Gonzalez, Graciela Castro Narro, Hugo Cheinquer, Fernando Contreras, Nelia Hernández, Christie Perelló, Ezequiel Ridruejo, ... José Luís Calleja

Ann Hepatol. 2025;30 Supl 2:101968

Full text access

Share

VALIDATION OF AGILE-3+ AND AGILE-4 SCORES FOR NONINVASIVE DETECTION OF FIBROSIS AND CIRRHOSIS IN METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE IN LATIN AMERICA

Carlos Esteban Coronel Castillo, Luis Antonio Díaz Piga, Natalia Baeza, Francisco Idalsoaga, Daniel Cabrera Garcia, Fernando Javier Barreyro, Sebastian Marciano, Jorge Martinez Morales, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:101969

Full text access

Share

EXPLORING THE ROLE OF METABOLIC DYSFUNCTION IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL STUDY

María Ignacia Pérez Garayar, Vania Cari Gormaz, Ignacio Téllez, Francisco Idalsoaga, Gene Im, Bastian Alcayaga, Muzzafar Haque, Stephanie Rutledge, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:101970

Full text access

Share

CHARACTERIZATION OF THE UNRECORDED ALCOHOL USE WORLDWIDE: A SYSTEMATIC REVIEW AND SURVEY-BASED STUDY

Katherine Emilia Maldonado Cardona, Hanna Blaney, Deepika Devuni, Muzzafar Haque, Pojsakorn Danpanichkul, Francisco Idalsoaga, Vinay Jahagirdar, Kaanthi Rama, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:101971

Full text access

Share

IDENTIFICATION OF NOVEL INTESTINAL MICROBIOTA-BASED MARKERS ASSOCIATED WITH DYSBIOSIS, SEPSIS AND SHORT-TERM MORTALITY IN ALCOHOL-RELATED DECOMPENSATED CIRRHOSIS AND ACUTE-ON-CHRONIC LIVER FAILURE

María Daniela Sánchez Gutiérrez, Paula Alejandra Castaño Jimenéz, Luis Gilberto Huerta Gómez, Marina Campos Valdez, Miriam Ruth Bueno Topete, Tonatiuh Abimael Baltazar Díaz

Ann Hepatol. 2025;30 Supl 2:101972

Full text access

Share

EFFECTS OF MELATONIN AND PHYSICAL EXERCISE ON SECONDARY BILIARY CIRRHOSIS

Marilda da Silva Brasil, Elizângela Gonçalves Schemitt, Sandielly Rebeca Benitez da Fonseca, Gabriela dos Santos Martins, Millena de Oliveira Engeroff, Giorgia Assoni, Lorenzo Cercal Britto, Cláudio Augusto Marroni, Norma Possa Marroni

Ann Hepatol. 2025;30 Supl 2:101973

Full text access

Share

ARTIFICIAL INTELLIGENCE FOR SURVIVAL PREDICTION IN HEPATOCELLULAR CARCINOMA: DEVELOPMENT AND VALIDATION OF A CLINICAL DATA–DRIVEN MODEL IN A COHORT OF 129 PATIENTS

Giovane Carvalho Viola, Rodolfo Viola, Renato Altikes, Claudia Tani, Flair Carrilho, Lisa Saud, Mário Pessoa, Aline Chagas, ... Claudia Oliveira

Ann Hepatol. 2025;30 Supl 2:101974

Full text access

Share

AUTOIMMUNE HEPATITIS IN LATIN AMERICA: INSIGHTS FROM THE ALLATIN COHORT

Ludmila Resende Guedes, Guilherme Grossi Lopes Cançado, Janaína Luz Narciso Schiavo, Luciana Costa Faria, Ezequiel Ridruejo, Maria Lucia Ferraz, Margarita Anders, Lorena Castro Solari, ... Cláudia Alves Couto

Ann Hepatol. 2025;30 Supl 2:101975

Full text access

Share

PROTECTIVE ROLE OF MTARC1 RS2642438 POLYMORPHISM AGAINST FIBROSIS PROGRESSION IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

Sofia Rocha, Claudia Oliveira Marques, Jose Tadeu Stefano, Raymundo Soares Azevedo, Michele Soares Gouvea, Patricia Momoyo Zitelli, Mario Guimaraes Pessoa, Joao Renato Rebello Pinho

Ann Hepatol. 2025;30 Supl 2:101976

Full text access

Share

INFLUENCE OF GLYCEMIC CONTROL ON THE SEVERITY OF HEPATIC STEATOLOGY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Yenni Joseline Cruz Ramírez, Reyna Sarai Velez Ramirez, Luis Erick Cardona Rodriguez, Mayra Virginia Ramos Gómez

Ann Hepatol. 2025;30 Supl 2:101977

Full text access

Share

BIOACTIVE COFFEE COMPOUNDS SYNERGISTICALLY ENHANCE THE ANTITUMOR EFFECTS OF CHEMO AND IMMUNOTHERAPY FOR HEPATOCELLULAR CARCINOMA IN VITRO

Leticia Valente Cardoso, Luana Casarin Riechelmann, Luis Barbisan Fernando, Guilherme Romualdo Ribeiro

Ann Hepatol. 2025;30 Supl 2:101978

Full text access

Share

INFLUENCE OF CARDIOMETABOLIC RISK FACTORS AND ALCOHOL CONSUMPTION ON LIVER STIFFNESS IN PATIENTS WITH MASLD: A MULTICENTER STUDY IN COLOMBIA

Ismael de Jesus Yepes Barreto, Nicole Chamorro, Guillermo Donado, Pablo Osorio, Juan Carlos Restrepo, Santiago Pino, Clara Caez, Jorge Ortiz, Yohana Poveda

Ann Hepatol. 2025;30 Supl 2:101979

Full text access

Share

HEALTH LITERACY AS A DETERMINANT OF FRAILTY IN PATIENTS WITH LIVER CIRRHOSIS

Ismael de Jesús Yepes Barreto, Nicole Chamorro, Guillermo Donado

Ann Hepatol. 2025;30 Supl 2:101980

Full text access

Share

PREVALENCE OF LIVER FIBROSIS IN RELATIVES OF PATIENTS WITH MASLD-RELATED CIRRHOSIS: A STUDY ON DEGREE OF KINSHIP

Ismael de Jesús Yepes Barreto, Nicole Chamorro, Guillermo Donado

Ann Hepatol. 2025;30 Supl 2:101981

Full text access

Share

RELATIONSHIP BETWEEN QUALITY OF LIFE AND AN EDUCATIONAL STRATEGY BASED ON THE INFORMATION NEEDS OF PATIENTS WITH COMPENSATED LIVER CIRRHOSIS

Ismael de Jesús Yepes Barreto, Yohana Poveda, Guillermo Donado

Ann Hepatol. 2025;30 Supl 2:101982

Full text access

Share

THE RELATIONSHIP BETWEEN QUALITY OF LIFE IN ADULT SUBJECTS WITH COMPENSATED LIVER CIRRHOSIS AND BACTERIAL OVERGROWTH

Nicole Chamorro Guzmán, Ismael de Jesús Yepes Barreto, Sindy Yohana Poveda Salinas

Ann Hepatol. 2025;30 Supl 2:101983

Full text access

Share

IMPROVEMENT OF CARDIOVASCULAR RISK ASSESSMENT ON A COHORT OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

Pedro Miguel Mattos Nogueira, Carlos Eduardo Cruz Marques, Breno Corrêa Vieira, Ana Carolina Cardoso, Natalia Wajbrot, Claudia Equi, Nathalie Carvalho Leite, Glaucia Moraes de Oliveira, Cristiane Villela-Nogueira

Ann Hepatol. 2025;30 Supl 2:101984

Full text access

Share

CHANGES IN BODY COMPOSITION AND HEPATIC ELASTOGRAPHY VALUES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AT A MEDICAL CENTER IN CARTAGENA – COLOMBIA, DURING THE PERIOD FROM OCTOBER 2023 TO JANUARY 2025

Arturo Jose Viera Oliveros, Ismael Yepes Barreto, Yohana Poveda Salinas, Fernando García del Risco

Ann Hepatol. 2025;30 Supl 2:101985

Full text access

Share

PLANT-DERIVED MONOTERPENE SYNERGIZES WITH SORAFENIB TO SUPPRESS DRUG-TRIGGERED HEPATOCELLULAR CARCINOMA IN ANIMALS

Amr Amin

Ann Hepatol. 2025;30 Supl 2:101986

Full text access

Share

CONNECTIVE TISSUE GROWTH FACTOR AS A MARKER OF FIBROSIS IN PATIENTS WITH CHOLESTASIS

Jessica Mejía Ramírez, Fatima Higuerade la Tijera, Carolina Guzman, Ángel Daniel Santana Vargas, Viridiana López Ladron de Guevara, Cristian Yamin Sánchez Sánchez, Diego Fernando Abendaño Rivera, Maria Argentina Díaz Castro, ... Jose Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2:101987

Full text access

Share

CONNECTIVE TISSUE GROWTH FACTOR ASSESSMENT: DETERMINATION OF CUT-OFF POINTS FOR LIVER FIBROSIS IN CHOLESTASIS

Jessica Mejía Ramírez, Fatima Higuera de la Tijera, Carolina Guzman, Ángel Daniel Santana Vargas, Viridiana López Ladron de Guevara, Cristian Yamin Sánchez Sánchez, Diego Fernando Abendaño Rivera, Maria Argentina Díaz Castro, ... Jose Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2:101988

Full text access

Share

EVALUATION OF RESPONSE TO SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO UDCA: A PILOT STUDY OF LIVER BIOPSIES FOLLOW UP

Alejandra Villamil, Daniela de la Viña, Eduardo Mullen, Ignacio Lucero, Juan Carlos Bandi

Ann Hepatol. 2025;30 Supl 2:101989

Full text access

Share

CORE MUTATIONS IN THE HBEAG-NEGATIVE STAGE ARE KEY DETERMINANTS OF HEPATITIS B VIRUS REPLICATION

Selene Leuzzi, Cecilia Garcia, Diego Flichman, Maria Mercedes Elizalde

Ann Hepatol. 2025;30 Supl 2:101990

Full text access

Share

METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE-RELATED SIGNIFICANT AND ADVANCED FIBROSIS' PREVALENCE IN BRAZIL AND THE ASSOCIATED ACCURACY OF FIB-4 AND VIBRATION-CONTROLLED ELASTOGRAPHY - A NATIONAL REGISTER

Cristiane Alves Villela-Nogueira, Cristiane Valle Tovo, Nathalie Carvalho Leite, Mário Reis Álvares-da-Silva, Claudia Alexandra Ivantes, Claudia Alves Couto, Giovanni Faria Silva, Edson Roberto Parise, ... Claudia P.M.S. Oliveira

Ann Hepatol. 2025;30 Supl 2:101991

Full text access

Share

DURATION OF TYPE 2 DIABETES AS A CLINICAL PREDICTOR OF LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE

Daniza Alexandra Contreras de los Santos, Invis Perez Mendez, Omar Ebrahim Ibrahim

Ann Hepatol. 2025;30 Supl 2:101992

Full text access

Share

FULL COMPLIANCE TO QUALITY INDICATORS IN ACUTE VARICEAL BLEEDING REDUCES 6-WEEK MORTALITY.

Edgar Suarez, Juan Carlos Montaño, Ezequiel Demirdjian, Diego Arufe

Ann Hepatol. 2025;30 Supl 2:101993

Full text access

Share

BLOOD MICROBIOTA ASSESSED BY NEXT-GENERATION SEQUENCING AND SYSTEMIC INFLAMMATION MARKERS IN ACUTE-ON-CHRONIC LIVER FAILURE: PILOT REPRESENTATIVE STUDY FROM WESTERN MEXICO

Paula Alejandra Castaño Jimenez, Tonatiuh Abimael Baltazar Díaz, Luis Gilberto Huerta Gómez, Ksenia Klimov Kravtchenko, Susana del Toro Arreola, Jesse Haramati, Luz Alicia González Hernández, Miriam Ruth Bueno Topete

Ann Hepatol. 2025;30 Supl 2:101994

Full text access

Share

ARTIFICIAL INTELLIGENCE IN PREDICTING THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH METABOLICALLY ASSOCIATED STEATOTIC LIVER DISEASE: DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL IN 306 PATIENTS

Giovane Carvalho Viola, Rodolfo Carvalho Viola, Regiane Alencar, Renato Altikes, Claudia Tani, Lisa Saud, Mario Pessoa, Aline Chagas, Claudia Oliveira

Ann Hepatol. 2025;30 Supl 2:101995

Full text access

Share

EFFICACY AND SAFETY OF ILEAL BILE ACID TRANSPORTER INHIBITORS IN ADULTS WITH AUTOIMMUNE CHOLESTATIC LIVER CONDITIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Igor Silveira Boechat, Rodolfo Augusto Rezende Assis, Carlos Alberto Leitão Neto Monteiro, Yohanna Idsabella Rossi, Marina Leite de Assis Bezerra Cavalcanti, Guilherme Grossi Lopes Cançado

Ann Hepatol. 2025;30 Supl 2:101996

Full text access

Share

THE ROLE OF GLYCEMIC CONTROL IN STEATOSIS AND HEPATIC FIBROSIS IN PATIENTS WITH A DIAGNOSIS OF TYPE 2 DIABETES MELLITUS

Yenni Joseline Cruz Ramírez, Miguel Angel Quiñonez Barrera, Mayra Virginia Ramos Gómez

Ann Hepatol. 2025;30 Supl 2:101997

Full text access

Share

IMPLEMENTATION OF A TEST AND TREAT MODEL FOR HCV CARE UTILIZING POINT OF CARE HCV RNA TESTING IN LA BODEGA

Anthony Martinez, Scott Springer, Sean Owen

Ann Hepatol. 2025;30 Supl 2:101998

Full text access

Share

STATIN-INDUCED LIVER INJURY: DATA FROM URUGUAYAN PROSPECTIVE HEPATOTOXICITY REGISTRY.

Yamila Montaño Rodríguez, María Noel Boldrini, Verónica Guido, Sara Pillajo, Paula Chiodi, Adriana Sánchez, Nelia Hernández

Ann Hepatol. 2025;30 Supl 2:101999

Full text access

Share

REAL-WORLD EFFECTIVENESS OF URSODEOXYCHOLIC ACID AND FIBRATES IN URUGUAYAN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

Noel Boldrini Arce, Yamila Montaño, Patricia Etchandy, Daniela Chiodi, Adriana Sánchez, Nelia Hernández

Ann Hepatol. 2025;30 Supl 2:102000

Full text access

Share

COVID-19 MANAGEMENT WITH PENTOXIFYLLINE IN PATIENTS WITH STEATOHEPATITIS

Miguel Angel Jimenez Luevano, Ana Emilia Jimenez Partida, Alejandro Bravo Cuellar, Miguel Angel Jimenez Partida, Yolanda Cortes Aguilar

Ann Hepatol. 2025;30 Supl 2:102001

Full text access

Share

EXPERIENCE IN THE TREATMENT OF HEPATITIS C IN PREGNANT PATIENTS AT THE HEPATITIS CLINIC OF THE VERACRUZ HIGH SPECIALTY HOSPITAL

Maria Teresa Guzmán Terrones, Eve Flynn Ferreira, Luis Del Carpio Orantes, Raúl Terrones Castro

Ann Hepatol. 2025;30 Supl 2:102002

Full text access

Share

INR-PLATELET RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN MEXICAN CIRRHOTIC PATIENTS

Cinthya Yatzel Mulato Briones, Raúl Ramírez Marcial, Maria del Rosario Herrero Maceda, Scherezada María Isabel Mejía Loza, Rodrigo Vázquez Pérez, María Isabel Astudillo Delgado, Alejandra Díaz García

Ann Hepatol. 2025;30 Supl 2:102003

Full text access

Share

LONGITUDINAL CHANGES IN STEATOTIC LIVER DISEASE SUBTYPE CLASSIFICATION AND SUBSEQUENT RISK OF MAJOR ADVERSE LIVER OUTCOMES

Pedro Raul Ochoa Allemant, Douglas Schaubel, David Kaplan, Marina Serper

Ann Hepatol. 2025;30 Supl 2:102004

Full text access

Share

ATORVASTATIN AND GENE EXPRESSION SIGNATURES IN HEPATOCARCINOGENESIS

Ezequiel Ridruejo, Lucia Coli, Jimmy Daza, Giselle Romero Caimi, Timo Itzel, Andreas Teufel, Laura Alvarez

Ann Hepatol. 2025;30 Supl 2:102005

Full text access

Share

REPRIORITIZING THE LIVER TRANSPLANT WAITING LIST: IMPACT OF AUTOMATIC MELD-NA 29 FOR REFRACTORY ASCITES

Guilherme Fontanini Massote, Rebecca Zaia Dias, Alisson Sousa Alves, Mariana Caleffi Carvalho, Isabela de Carvalho Dourado, Roberta Araújo Chaves, Fernanda Souza Fernandes, Ajith Sankarankutty Kumar

Ann Hepatol. 2025;30 Supl 2:102006

Full text access

Share

PRIMARY MALIGNANT LIVER TUMORS: A 20-YEAR RETROSPECTIVE POSTMORTEM REVIEW

Jessica Mejía Ramírez, Fatima Higuera de la Tijera, Gerardo Aristi Urista, A. Paola Escobedo Zuñiga, Paola Daniela Guerrero Ramírez, Félix Alberto Pérez Cardenas, Jose Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2:102007

Full text access

Share

ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED VASCULAR EVENTS ARE AN UNDERRECOGNIZED CAUSE OF MORBIDITY AND MORTALITY AFTER LIVER TRANSPLANTATION: BENEFIT OF PLASMAPHERESIS AND ANTICOAGULATION IN TRANSPLANTED PATIENTS WITH HIGH THROMBOTIC RISK

Sofía Tejada, Walter González, Eduardo De Santibañes, Ignacio Lucero, Juan Carlos Bandi, Alejandra Villamil

Ann Hepatol. 2025;30 Supl 2:102008

Full text access

Share

ASSESSMENT OF FIBROSIS AND STEATOSIS IN PATIENTS WITH METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE USING TWO TRANSIENT ELASTOGRAPHY TECHNIQUES

Marlyn Zamora Posada, David Castellanos Alfonso, Martin Garzon Olarte, Mario Rey Tovar

Ann Hepatol. 2025;30 Supl 2:102009

Full text access

Share

FROM PATIENT TO EXPERT: EDUCATION FOR SELF-MANAGEMENT OF HEPATOCELLULAR CARCINOMA IN A CLINICAL EXCELLENCE PROGRAM

William Hernando Jiménez Mariño, Angélica María Sanabria Jiménez, María del Rosario Ariza de la Hoz, Oscar Alfredo Beltrán Galvis, María Cristina Torres Caro, Diana Carolina Salinas Gómez, Martín Garzón Jiménez, Geovanny Hernández Cely, Adriana Varón Puerta

Ann Hepatol. 2025;30 Supl 2:102010

Full text access

Share

NON-INVASIVE HEMODYNAMIC ASSESSMENT IN CIRRHOSIS: CHILD-PUGH STRATIFICATION AND A PLATELET THRESHOLD TO DEFINE THE HYPERDYNAMIC STATE

Martín Elizondo, Eugenia Ipar, Romina Rey, Leandro Cymberknop, Marcelo Valverde, Solange Gerona, Ricardo Armentano

Ann Hepatol. 2025;30 Supl 2:102011

Full text access

Share

IRON METABOLISM DISTURBANCES ARE ASSOCIATED WITH LIVER FIBROSIS SEVERITY IN MASLD: A CROSS-SECTIONAL STUDY USING NON-INVASIVE TOOLS

Romina Rey Laguarda, Martín Elizondo Barceló, Lain Lin Liu, Emilia Moreira Milanesi, Solange Gerona Sangiovanni

Ann Hepatol. 2025;30 Supl 2:102012

Full text access

Share

AMA-NEGATIVE PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: A DISTINCT SUBSET WITH LOWER TREATMENT RESPONSE

Claudia Alves Couto, Guilherme Grossi Lopes Cançado, María Lucía Ferraz Ferraz, Debora Raquel Terrabuio, Alejandra Villamil, Lorena Castro Solari, Graciela Elia Castro-Narro, Ezequiel Ridruejo, ... Nélia Hernandez

Ann Hepatol. 2025;30 Supl 2:102013

Full text access

Share

FIBRATES SEEM TO BE EQUALLY EFFECTIVE AS SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS, WITH BIOCHEMICAL RESPONSE PLATEAUING AT 6 MONTHS

Guilherme Grossi Lopes Cançado, María Lucía Ferraz, Debora Raquel Benedita Terrabuio, Alejandra Villamil, Lorena Castro Solari, Graciela Elia Castro-Narro, Ezequiel Ridruejo, Cristiane A. Villela-Nogueira, ... Claudia Alves Couto

Ann Hepatol. 2025;30 Supl 2:102014

Full text access

Share

FUELING THE FIRE: INFECTIONS TRIGGER AND MALNUTRITION DRIVES SEVERE ACLF IN CIRRHOSIS

Silvia Cvekova

Ann Hepatol. 2025;30 Supl 2:102015

Full text access

Share

SPLEEN STIFFNESS PREDICTS ESOPHAGEAL VARICES IN LATIN AMERICAN CIRRHOTIC PATIENTS: CLINICAL AND ENDOSCOPIC CORRELATIONS

Martín Elizondo, Eugenia Ipar, Romina Rey, Leandro Cymberknop, Marcelo Valverde, Ricardo Armentano, Solange Gerona

Ann Hepatol. 2025;30 Supl 2:102016

Full text access

Share

VISCERAL FAT AS A KEY DRIVER OF LIVER FIBROSIS IN MASLD: A DXA-BASED ANALYSIS

Jenaine Rosa Emiliano Godinho, Raul Donizetti Moraes Silva, Lívia Manéa Petri, Ana Cecilia Sartori Ferruzzi, Jordanna de Paula Torres, Henrique Pezzin Sario, João Marcello de Araújo-Neto, Maria Auxiliadora Nogueira Saad, ... Débora Vieira Soares

Ann Hepatol. 2025;30 Supl 2:102017

Full text access

Share

NON-INVASIVE ASSESSMENT OF STEATOHEPATITIS AND LIVER FIBROSIS IN THE POPULATION AT RISK FOR METABOLIC STEATOTIC LIVER DISEASE

Laís Siqueira Maia, Juliana Rodrigues Caldas, Rodrigo Nogueira Alonso, Juliana de Albuquerque Magella Mussnich, Maria Paula Silva Bernardes, João Marcello Neto de Araújo, Luis Guillermo Coca Velarde, Maria Auxiliadora Nogueira Saad, ... Priscila Pollo-Flores

Ann Hepatol. 2025;30 Supl 2:102018

Full text access

Share

IMPACT OF DIRECT-ACTING ANTIVIRALS ON THE FIB-4 INDEX IN PATIENTS WITH CHRONIC HEPATITIS C AND SUSTAINED VIROLOGICAL RESPONSE.

Raúl Ramírez Marcial, Scherezada María Isabel Mejía Loza, María del Rosario Herrero Maceda, Rodrigo Vázquez Pérez, Oswaldo Pavel Cervantes Gutiérrez

Ann Hepatol. 2025;30 Supl 2:102019

Full text access

Share

NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IN THE POPULATION WITH TYPE 2 DIABETES AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

Laís Siqueira Maia, Luisa Lara Calazans, Luana Luna de Castro, Filipe Giordano Valerio, David Ramos Pinho, Igor Ishakewitsch Henrique Silva, Tamires Nascimento Dos Santos, Luis Guillermo Coca Velarde, ... Priscila Pollo-Flores

Ann Hepatol. 2025;30 Supl 2:102020

Full text access

Share

FREQUENCY OF HEPATITIS A ANTIBODIES IN PATIENTS ATTENDING CONSULTATION FOR ABNORMAL LIVER FUNCTION TESTS

Hugo Cedron Cheng

Ann Hepatol. 2025;30 Supl 2:102021

Full text access

Share

PRESENTATION AND FOLLOW-UP OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER THROUGH 2005-2022 AT A LIVER TRANSPLANT UNIT IN BOGOTA, COLOMBIA

Lina Dorado Delgado, Daniel Valery Rojas Kozhakin, Aura Blanco, Geovanny Hernandez, Carolina Salinas, Cristina Torres, Oscar Beltran, Martin Garzón, Adriana Varon

Ann Hepatol. 2025;30 Supl 2:102022

Full text access

Share

LIPOUNITS: A NOVEL UNIT OF MEASUREMENT TO COMMUNICATE THE IMPACT OF DAILY HABITS ON LIVER FAT IN PATIENTS WITH MASLD

Ismael de Jesus Yepes Barreto, Maria Fernanda Saavedra, Dalis Pérez Fortich

Ann Hepatol. 2025;30 Supl 2:102023

Full text access

Share

STOP PPIS - NO REDUCTION IN BLEEDING OR MORTALITY AFTER ENDOSCOPIC BANDING LIGATION FOR ESOPHAGEAL VARICES IN CIRRHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Gustavo André Pedral Diniz Leite, Bernardo de Faria Moraes, Gabriel André Pedral Diniz Leite, Maria Luisa Motta Fonseca, Rodolfo Augusto Assis Rezende, Guilherme Grossi Lopes Cançado

Ann Hepatol. 2025;30 Supl 2:102024

Full text access

Share

HIGH WAITING LIST MORTALITY AMONG LIVER TRANSPLANT CANDIDATES WITH ALCOHOL-RELATED LIVER DISEASE: A 10-YEAR COHORT FROM A BRAZILIAN TERTIARY CENTER

Guilherme Fontanini Massote, Roberta Araújo Chaves, Verena da Silva Ayub, Fernanda Souza Fernandes, Ajith Sankarankutty Kumar

Ann Hepatol. 2025;30 Supl 2:102025

Full text access

Share

ENCEPHALAPP STROOP TO DETECT COVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH COMPENSATED CIRRHOSIS

Oscar Suazo, Kemo Sayon, Yusimik Román, Sila M. Gonzales, Mirtha Infante Velasquez, Marlén Castellanos, Danay Guerrero, Susana Borges

Ann Hepatol. 2025;30 Supl 2:102026

Full text access

Share

PREVALENCE OF COVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS

Oscar Suazo, Aissatou Sow, Susana Borges, Marlén Castellanos, Sila M. Gonzales, Danay Guerrero, Mirtha Infante Velasquez, Yusimik Román

Ann Hepatol. 2025;30 Supl 2:102027

Full text access

Share

LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: IMPLICATIONS OF EXPANDING AGE LIMITS IN LOW-DONATION SETTINGS IN LATIN AMERICA

Maria Fernanda Lynch-Mejía, Francisco Vargas-Navarro, Wagner Ramírez-Quesada, Maria José Soto-Echeverri, Andrés Solera-Vega, Alejandra Ochoa-Palominos, Pablo Coste

Ann Hepatol. 2025;30 Supl 2:102028

Full text access

Share

CHARACTERIZATION AND DESCRIPTION OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE ASSESSED BY HEPATIC ELASTOGRAPHY IN A CENTER IN BOGOTA

Lina Marcela Dorado Delgado, Laura Cristina Arocha Dugand, Martin Alonso Garzón Olarte, Danna Lesley Cruz Reyes, Nicole Guzmán, Oscar Beltrán, Geovanny Hernández, Carolina Salinas, ... Adriana Varón Puerta

Ann Hepatol. 2025;30 Supl 2:102029

Full text access

Share

CLINICAL CHARACTERIZATION OF HCC IN A SILENT REGION: REAL-WORLD DATA FROM A PROSPECTIVE COHORT IN CENTRAL AMERICA

Francisco Vargas-Navarro, Maria Lynch-Mejía, Wagner Ramírez-Quesada, Maria Soto-Echeverri, Daniel Pérez-Muñoz, Alejandra Ochoa-Palominos, Pablo Coste

Ann Hepatol. 2025;30 Supl 2:102030

Full text access

Share

VIRULENCE–HOST GENE INTERACTION OF H. PYLORI CAGA AND NOD1 ELEVATES NON-INVASIVE FIBROSIS MARKERS IN MASLD

Facundo Maiorana, Kiara Czajkowski, Enzo Gabriel Maidana, Maria Virginia Caronia, Pedro Dario Zapata, Fernando Javier Barreyro

Ann Hepatol. 2025;30 Supl 2:102031

Full text access

Share

CONCORDANCE BETWEEN EXPERT GASTROENTEROLOGISTS AND ARTIFICIAL INTELLIGENCE TOOLS IN SOLVING HEPATOLOGY CLINICAL CASES

Jesús Ignacio Mazadiego Cid, María del Rosario Herrero Maceda, Paloma Montserrat Diego Salazar, Rogelio Zapata Arenas, Scherezada María Isabel Mejía Loza, Juanita Pérez Escobar, María Fátima Higuera de la Tijera, Elías Artemio San Vicente Parada, ... Alejandra Díaz García

Ann Hepatol. 2025;30 Supl 2:102032

Full text access

Share

HIGH RATE OF EARLY ALP NORMALIZATION WITH UDCA–BEZAFIBRATE COMBINATION THERAPY IN TREATMENT-NAÏVE PRIMARY BILIARY CHOLANGITIS: PRELIMINARY RESULTS

Juan Antonio Sorda, Fernando Javier Barreyro, Matías Bori, Guillermo Fernández, Esteban González Ballerga

Ann Hepatol. 2025;30 Supl 2:102033

Full text access

Share

STEATOTIC HEPATOCYTES SHOWN REDUCED CYP450 EXPRESSION AND IN VITRO RESISTANCE TO DRUG-INDUCED TOXICITYSTEATOTIC HEPATOCYTES SHOWN REDUCED CYP450 EXPRESSION AND IN VITRO RESISTANCE TO DRUG-INDUCED TOXICITY

Johanna Carolina Arroyave Ospina, Fabio Aguilar, Yana Geng, Fabian M. Cortes Mancerra, Manon Buist-Homan, Han Moshage

Ann Hepatol. 2025;30 Supl 2:102034

Full text access

Share

PROJECTED CLINICAL AND ECONOMIC BURDEN OF METABOLIC DYSFUNCTION–ASSOCIATED STEATOHEPATITIS IN BRAZIL: A 20-YEAR FORECAST ACROSS TYPE 2 DIABETES STATUS

Zobair Younossi, James M. Paik, Cristiane A. Villela-Nogueira, Claudia Pinto Oliveira, Fatema Nader, Linda Henry, Mário Guimarães Pessoa

Ann Hepatol. 2025;30 Supl 2:102035

Full text access

Share

STUDY OF METABOLIC DYSFUNCTION ASSOCIATED WITH ESTABLISHED LIVER DISEASE USING FLI AND HSI INDICES IN THE ADULT POPULATION OF CUQUÍO, JALISCO, MEXICO

Martha Eloisa Ramos Marquez, Omar González Carrillo, Mariana Rivas Paz, Ma. del Carmen Carrillo Pérez

Ann Hepatol. 2025;30 Supl 2:102036

Full text access

Share

HIGH PREVALENCE OF DILI/HILI IN A CENTER PARTICIPATING IN A MULTICENTER STUDY FOR DIAGNOSING ACUTE HEPATITIS IN BRAZIL

Tayna da Silva Domingos, Vinicius Santos Nunes, Luiz Antônio Rodrigues de Freitas, Sidelcina Rugeri Pacheco, Raymundo Paraná Ferreira Filho, Maria Isabel Schinoni

Ann Hepatol. 2025;30 Supl 2:102037

Full text access

Share

TRANSPLANT-FREE SURVIVAL AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA MANAGED AT A TERTIARY REFERRAL HOSPITAL IN PERU

Mariella Rosalina Huaman Rivera, Diego Francisco Pinto Ruiz, Estefania Liza Baca, Zuly Placido Damian, Javier Diaz Ferrer

Ann Hepatol. 2025;30 Supl 2:102038

Full text access

Share

PREDICTIVE FACTORS OF RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN MEXICAN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

Fátima Higuera de la Tijera, Graciela Elia Castro Narro, Ana Cano Contreras, José Luis Pérez Hernández, Jorge Emilio Lira Vera, José Antonio Velarde Ruiz Velasco

Ann Hepatol. 2025;30 Supl 2:102039

Full text access

Share

FROM POLICY TO PRACTICE: HEPATITIS C CARE INDICATORS IN URUGUAY BEFORE AND AFTER THE INTRODUCTION OF PUBLIC HEALTH STRATEGIES

Victoria Mainardi, Susana Cabrera, Luciana Noble, Daniela Olivari, Solange Gerona, Sebastian Marciano, Huaiyang Zhong, Julio Medina

Ann Hepatol. 2025;30 Supl 2:102040

Full text access

Share

CHARACTERIZATION OF PATIENTS CO-INFECTED WITH HEPATITIS C AND HIV IN THE NORTH REGION OF BRAZ

Isabelle Cristine de Jesus Macedo, Aline Alves da Silva, Elton Carlos de Almeida, João Vitor da Mota Silva, Carla Francisca dos Santos Cruz, Ana Paula Maciel Gurski, Ana Monica de Mello, Nathália da Silva Cruz, ... Leonardo Carrara Matsuura

Ann Hepatol. 2025;30 Supl 2:102041

Full text access

Share

DATA OMISSION IN COMPULSORY NOTIFICATION FORMS RELATED TO HEPATITIS A, B AND C AND HIV CO-INFECTION

Isabelle Cristine de Jesus Macedo, João Vitor da Mota Silva, Ana Paula Maciel Gurski, Mário Peribanez Gonzalez, Elton Carlos de Almeida, Aline Alves da Silva, Ana Monica de Mello, Carla Francisca dos Santos Cruz, ... Leonardo Carrara Matsuura

Ann Hepatol. 2025;30 Supl 2:102042

Full text access

Share

IMPACT OF HEPATITIS A VACCINATION IN PRIORITY ADULT GROUPS AS AN OUTBREAK CONTAINMENT STRATEGY IN BRAZIL

Isabelle Cristine de Jesus Macedo, Aline Alves da Silva, Nathalia da Silva Cruz, Elton Carlos de Almeida, Ana Paula Maciel Gurski, Joao Vitor da Mota Silva, Carla Francisca dos Santos Cruz, Ana Monica de Mello, ... Leonardo Carrara Matsuura

Ann Hepatol. 2025;30 Supl 2:102043

Full text access

Share

GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA

Cassio Marques Perlin, Melina Keingeski Belén, Bruno de Souza Basso, Beatriz Mendes Borba, Julliane Dutra Medeiros, Francis Moreira Borges, Bernd Schnabl, Mario Reis Alvares-da-Silva

Ann Hepatol. 2025;30 Supl 2:102044

Full text access

Share

NURSING CARE STRATEGIES FOR INDIVIDUALS WITH VIRAL HEPATITIS IN THE CONTEXT OF PRIMARY HEALTH CARE

Joao Vítor da Silva Mota, Ana Paula Maciel Gurski, Carla Francisca dos Santos Cruz, Mario Peribanez Gonzalez, Elton Carlos de Almeida, Aline Alves da Silva, Ana Mônica de Mello, Nathalia da Silva Cruz, ... Leonardo Carrara Matsuura

Ann Hepatol. 2025;30 Supl 2:102045

Full text access

Share

GEOREFERENCING AS A MANAGEMENT STRATEGY FOR SITUATIONAL DIAGNOSIS OF THE TERRITORY IN THE CARE OF VIRAL HEPATITIS

João Vítor da Mota Silva, Aline Alves da Silva, Elton Carlos de Almeida, Leonardo Carrara Matsuura, Isabelle Cristine de Jesus Macedo, Ana Paula Maciel Gurski, Ana Mônica de Mello, José Nilton Neris Gomes, ... Nathalia da Silva Cruz

Ann Hepatol. 2025;30 Supl 2:102046

Full text access

Share

WHAT IS THE PROGNOSTIC VALUE OF A BLOOD TEST COUNT IN PATIENTS WITH ALCOHOLIC HEPATITIS?

Moisés Coutiño Flores, Katy Alejandra Sánchez Pozos, Gabriela Bretón Arroy, Lucia Amairani Robles Casanova, Jesús Ignacio Mazadiego Cid, Antonio Coutiño Flores, María del Rosario Herrero Maceda, Scherezada María Isabel Mejia Loza

Ann Hepatol. 2025;30 Supl 2:102047

Full text access

Share

ATORVASTATIN AND RIFAXIMIN IN THYROID PREVENT LIVER THYROID METABOLISM ABNORMALITIES IN HEPATOCELLULAR CARCINOMA: IN VITRO AND IN VIVO STUDY

Bruno de Souza Basso, Thaliane Carvalho de Oliveira, Rachel Pinto Dornelles, Daiane Dias Cabeleira, Elisa Carolina Lange, Cristiane Gisele Gomes, Emanuela Tureta Cagnini, Luca Prá Scherer, ... Mario Reis Alvares-da-Silva

Ann Hepatol. 2025;30 Supl 2:102048

Full text access

Share

DIFFERENT LIPIDOMIC SIGNATURE IN EXTRACELLULAR VESICLES IN PATIENTS WITH MASLD- HCC: ANALYSIS OF DIFFERENT STAGES OF MASLD

Mario Reis Alvares-da-Silva, Melina Keingeski Belén, Larisse Longo, Bruno de Souza Basso, Jose Tadeu Stefano, Claudia Pinto Oliveira, Carolina Uribe-Cruz, Juan Pablo Arab Verdugo

Ann Hepatol. 2025;30 Supl 2:102049

Full text access

Share

NEW INSIGHTS INTO THYROID HORMONE METABOLISM AND AMMONIA DETOXIFICATION IN MASLD USING N-ACETYLCYSTEINE (NAC) AND L-ORNITHINE L-ASPARTATE (LOLA)

Emanuela Tureta Cagnini, Bruno de Souza Basso, Elisa Carolina Lange, Thaliane Carvalho de Oliveira, Milla Paim Dreher, Daiane Dias Cabeleira, Jessica Sindo, Maria Ines Gonzales Solari, ... Mario Alvares-da-Silva Reis

Ann Hepatol. 2025;30 Supl 2:102050

Full text access

Share

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS PREVIOUSLY TREATED WITH FIBRATES OR OBETICHOLIC ACID

Alejandra M. Villamil, Daniel Pratt, Andreas E. Kremer, Vincenza Calvaruso, Elena Gómez Dominguez, Xin Qi, Sarah Proehl, William T. Barchuk, ... Stuart C. Gordon

Ann Hepatol. 2025;30 Supl 2:102051

Full text access

Share

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED CIRRHOSIS IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE TRIAL

Alejandra M. Villamil, Ziad Younes, Christopher L. Bowlus, John M. Vierling, Adam Vasura, Andrea Galli, Mordechai Rabinovitz, Frederik Nevens, ... Eric J. Lawitz

Ann Hepatol. 2025;30 Supl 2:102052

Full text access

Share

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF HEPATOCELLULAR CARCINOMA IN A REFERRAL HOSPITAL IN LIMA, PERU

Fortunato Sandro Príncipe Meneses, Zuly Placido Damian, Estefania Liza Baca, Javier Díaz Ferrer

Ann Hepatol. 2025;30 Supl 2:102053

Full text access

Share

IMPORTANCE OF P450 POLYMORPHISM IN THE DEVELOPMENT OF DILI/HILI: HISTOLOGICAL AND BIOCHEMICAL FINDINGS

Tayna da Silva Domingos, Vinicius Santos Nunes, Luiz Antônio Rodrigues de Freitas, Genario Oliveira Santos Júnior, Raymundo Paraná Ferreira Filho, Maria Schinoni Protti

Ann Hepatol. 2025;30 Supl 2:102054

Full text access

Share

SARCOPENIA IS A KEY DETERMINANT MARKER OF LEAN MASLD: A COMPARATIVE ANALYSIS OF CLINICAL PROFILE, BODY COMPOSITION BY DEXA, AND MUSCLE STRENGTH IN LEAN, OVERWEIGHT, AND OBESE MASLD PATIENTS

Marcella Motta Lucindo Duarte, Fernanda B.V. Coelho, Daniele Helena Faray Cortez da Silva, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Patrícia Momoyo Yoshimura Zitelli, José Tadeu Stefano, Hamilton Roschel, ... Claudia P. Oliveira

Ann Hepatol. 2025;30 Supl 2:102055

Full text access

Share

CLINICAL PROFILE AND SURVIVAL IN SEVERE ALCOHOL-RELATED LIVER DISEASE: A RETROSPECTIVE STUDY FROM A REFERRAL HOSPITAL IN PERU

Mayumi Tacuri Arqque, Carlos Aurelio Garcia Encinas, Alejandro Ugarte Lastra, David Guevara Lazo

Ann Hepatol. 2025;30 Supl 2:102056

Full text access

Share

ANALYSIS OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND C-REACTIVE PROTEIN IN CIRRHOTIC PATIENTS WITH BACTERIAL, FUNGAL, AND VIRAL INFECTIONS: A CROSS-SECTIONAL STUDY

Ana Caroline Martins Oliveira, Karin Kristie Santos Oliveira, João Vitor Ferreira Freire, Isabelle Santos da Silva, Bruna Moraes Carvalho, Maria Schinoni Protti

Ann Hepatol. 2025;30 Supl 2:102057

Full text access

Share

CLINICAL CHARACTERISTICS AND SAFETY PROFILE OF ATEZOLIZUMAB/BEVACIZUMAB IN CARCINOMA HEPATOCELLULAR: EXPERIENCE OF A CENTER OF REFERENCE NATIONAL IN PERU

Jairo Cabanillas Espinoza, Estefania Liza Baca, Javier Díaz Ferrer

Ann Hepatol. 2025;30 Supl 2:102058

Full text access

Share

LOCAL EXPERIENCE USING THE ULTRASOUND VISUALIZATION SCORE IN HEPATOCELLULAR CARCINOMA SCREENING

Blanca Norero Muñoz, Victor Rebolledo Muñoz, Claudio Montenegro Navarrete, Joel Fuentes Espinoza, Andres Yoma Troncoso, Rocio Contreras Aravena, Viviana Riquelme Sepúlveda, Consuelo Rentería Araya, ... Rodrigo Wolff Rojas

Ann Hepatol. 2025;30 Supl 2:102059

Full text access

Share

ENZIMATICALLY MODIFIED QUERCETIN PREVENTS FIBROSIS PROGRESSION IN CHEMICALLY INDUCED LIVER CANCER IN WISTAR RATS

Marina Campos Valdez, Karla Verónica Teymennet Ramírez, José Alfredo Domínguez Rosales, Juliana Marisol Godínez Rubí, Erika Martínez López, Guillermo Moisés Zúñiga González, Iliana del Carmen Barrera Martínez, Laura Verónica Sánchez Orozco

Ann Hepatol. 2025;30 Supl 2:102060

Full text access

Share

MORINGA OLEIFERA LEAF AQUEOUS EXTRACT IMPROVES SURVIVAL IN A LIVER CANCER MODEL IN WISTAR RATS

Laura Verónica Sánchez Orozco, Jaime Sánchez Meza, Marina Campos Valdez, Amador Campos Valdez, José Alfredo Rosales Domínguez, Juliana Marisol Godínez Rubí, Sarai Citlalic Rodríguez Reyes, Erika Martínez López, ... Leticia Casas Godoy

Ann Hepatol. 2025;30 Supl 2:102061

Full text access

Share

INCIDENCE AND PREDICTORS OF POST-TRANSPLANT MALIGNANCY IN LIVER TRANSPLANT RECIPIENTS: A SINGLE-CENTRE COHORT STUDY

Francisco Idalsoaga F., Pedro Acuña V., Abed Saqah, Hashaal Alkhurassi, Saad Moteb Aldosari, Abdelrahman Sallam, Rayad Elzaanoun, Siddhant Maini, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:102062

Full text access

Share

THERAPEUTIC PLASMA EXCHANGE-INDUCED SHIFTS IN BILE SALT COMPOSITION IN ALCOHOL-ASSOCIATED HEPATITIS: INSIGHTS INTO MECHANISMS AND THERAPEUTIC POTENTIAL

Francisco Idalsoaga F., Pedro Acuña V., Paula Rivera, Luis Antonio Díaz Piga, Fidel Allende, Sandra Solari, Nancy Solis, Daniel Havaj, ... Lubomir Skladany

Ann Hepatol. 2025;30 Supl 2:102063

Full text access

Share

HEPATITIS C AMONG PEOPLE EXPERIENCING HOMELESSNESS IN CHILE: PREVALENCE AND ASSOCIATED FACTORS

Francisco Idalsoaga F., Pedro Acuña V., Luis Antonio Díaz Piga, Hanna Blaney, Camila Picchio, Fernanda Contreras, Barbara Ricouz, David Salinas, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:102064

Full text access

Share

MORTALITY TRENDS AND RISK FACTORS IN ALCOHOL-ASSOCIATED HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Francisco Idalsoaga F., Pedro Acuña V., Mushfiqur Haque, Muzzafar Haque, Luis Antonio Díaz Piga, Gene Im, Ashwani Singal, Stephen Hoang, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:102065

Full text access

Share

LIVER DISEASE BURDEN AND MORTALITY AMONG PEOPLE EXPERIENCING HOMELESSNESS IN CHILE: A RETROSPECTIVE COHORT STUDY

Francisco Idalsoaga F., Pedro Acuña V., Luis Antonio Díaz Piga, Fernanda Contreras, Oscar Gatica, Josefina Marcenaro, Dominga Garcia, Diego Bustos, ... Juan Pablo Arab

Ann Hepatol. 2025;30 Supl 2:102066

Full text access

Share

BILE ACID PROFILES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

Maria Ayala Valverde, Nancy Solis, Francisca Allendes, Francisco Barrera, Jorge Arnold Alvarez, Cristina Alonso, Juan Pablo Arab, Daniel Cabrera, ... Marco Arrese

Ann Hepatol. 2025;30 Supl 2:102067

Full text access

Share

RISK FACTORS ASSOCIATED WITH ADVANCED LIVER FIBROSIS IN PATIENTS WITH MASLD AT A PRIVATE CLINIC IN PERU

Fernando Junior Contreras Vargas, Javier Omar Díaz Ferrer

Ann Hepatol. 2025;30 Supl 2:102068

Full text access

Share

NON-INVASIVE SERUM BIOMARKERS TO PREDICT ADVANCED FIBROSIS IN AUTOIMMUNE HEPATITIS IN MEXICAN POPULATION: RPR AND HALP-SCORE

Eulalio Alberto Gutiérrez Rodríguez, Manuel Alejandro Cornejo Gutiérrez, Alejandro Tovar Durán, Julio Alexis Arce Hernández, Juan José Mendoza Rodríguez

Ann Hepatol. 2025;30 Supl 2:102069

Full text access

Share

EFFECTS OF MELATONIN AND PHYSICAL EXERCISE ON THE ANALYSIS OF THE INTESTINAL MICROBIOTA IN AN EXPERIMENTAL MODEL OF CIRRHOSIS: COMPOSITION, DIVERSITY AND FUNCTIONAL CHANGES

Elizângela Gonçalves Schemitt, Gabriela dos Santos Martins, Sandielly Rebeca Benitez da Fonseca, Marilda da Silva Brasil, Millena de Oliveira Engeroff, Giorgia Assoni, Lorenzo Cercal Britto, Cláudio Augusto Marroni, Norma Possa Marroni

Ann Hepatol. 2025;30 Supl 2:102070

Full text access

Share

CHOLANGIOCARCINOMA, CHARACTERISTICS AND PRESENTATION IN A REFERRAL HOSPITAL IN LIMA, PERU

Luis Andrés Huamán Berna, Cesar Ale Olazabal, Estefania Liza Baca, Zuly Plácido Damian, Javier Diaz Ferrer

Ann Hepatol. 2025;30 Supl 2:102071

Full text access

Share

ACTION OF MELATONIN AND PHYSICAL EXERCISE IN HEPATOPULMONARY SYNDROME

Sandielly Rebeca Benitez da Fonseca, Elizângela Gonçalves Schemitt, Gabriela dos Santos Martins, Marilda da Silva Brasil, Millena de Oliveira Engeroff, Giorgia Assoni, Lorenzo Cercal Britto, Cláudio Augusto Marroni, Norma Possa Marroni

Ann Hepatol. 2025;30 Supl 2:102072

Full text access

Share

LIVER TRANSPLANTATION IN PERU (2016–2024): TRENDS, CHALLENGES, AND GEOGRAPHIC DISPARITIES

David Guevara Lazo, Natalia Nombera Aznaran, Renzo Sebastian Zeballos Gonzalez, Roxana Aznaran Torres, Jorge Luis Garavito Rentería

Ann Hepatol. 2025;30 Supl 2:102073

Full text access

Share

AMA-NEGATIVE VS AMA-POSITIVE PRIMARY BILIARY CHOLANGITIS: ARE THERE ANY DIFFERENCES?

Matías Sebastián Bori, Juan Antonio Sordá, Ilse Sorena Pardo Ivirico, Andrea Curia, Jesús Gelvez, Esteban González Ballerga

Ann Hepatol. 2025;30 Supl 2:102074

Full text access

Share

STEATOSIS AND HEPATIC FIBROSIS IN PEDIATRIC POPULATION WITH OVERWEIGHT OR OBESITY BY TRANSITION ELASTOGRAPHY.

Jessica Mejía Ramírez, Fatima Higuera De la Tijera, Ángel Daniel Santana Vargas, Nayeli Garibay Nieto, Erendira Villanueva Ortega, Adrián A. Farret Ramos, Norma P. Salas Hernández, Isabel Omaña Guzman, Jose Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2:102075

Full text access

Share

ELIMINATION OF HEPATITIS C AMONG HEMODIALYSIS PATIENTS IN ALAGOAS, BRAZIL

Natalia Ramos, Denes Carvalho, Ana Beatriz Lima, Jeremy Oliveira, Maria Eliete Pinheiro, Andréa Omena, Leila Maria Lima

Ann Hepatol. 2025;30 Supl 2:102076

Full text access

Share

LIVER-INTESTINE AXIS IN CIRRHOSIS: EFFECTS OF MODERATE PHYSICAL EXERCISE AND MELATONIN ON INTESTINAL DAMAGE

Gabriela dos Santos Martins, Henrique Sarubbi Fillmann, Elizângela Gonçalves Schemitt, Marilda da Silva Brasil, Sandielly Rebeca Benitez da Fonseca, Millena de Oliveira Engeroff, Giorgia Assoni, Lorenzo Cercal Britto, ... Norma Possa Marroni

Ann Hepatol. 2025;30 Supl 2:102077

Full text access

Share

ASSESSMENT OF LIPID PROFILE AND ESTIMATED CARDIOVASCULAR RISK IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

Rodrigo Toledo Galván, Deborah Ernestina Espinoza López, Maria Beatriz Jourdan Rodriguez, Viridiana López Ladrón de Guevara, María de Fátima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102078

Full text access

Share

FRAILTY ASSESSMENT IN LIVER TRANSPLANT CANDIDATES AND ITS IMPACT ON DECISION-MAKING – A LATIN AMERICAN SURVEY

Nicolás Ignacio Lama Arriagada, George Therapondos, Laura Tenorio

Ann Hepatol. 2025;30 Supl 2:102079

Full text access

Share

NEUROCOGNITIVE IMPAIRMENT ASSESSMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS USING THE MINI-MENTAL STATE EXAMINATION IN A TERTIARY CARE HOSPITAL

Deborah Espinoza Lopez, Rodrigo Toledo Galvan, Maria Beatriz Jourdan Rodriguez, Viridiana Lopez Ladron de Guevara, Maria de Fatima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102080

Full text access

Share

PROGNOSTIC VALUE OF AST/ALT AND GGT/ALP RATIOS IN PATIENTS WITH CHOLANGIOCARCINOMA

Rodrigo Toledo Galván, Deborah Ernestina Espinoza López, Rocio del Carmen Baltazar Contreras, María de Fátima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102081

Full text access

Share

MICRO-ELIMINATION OF HEPATITIS C IN ADDICTION CENTERS: SCREENING GAPS AND AWARENESS BARRIERS IN ARGENTINA

Matías Sebastián Bori, Ilse Sorena Pardo Ivirico, Jesús Gelvez, Natalia Vera, Andrea Curia, Esteban González Ballerga

Ann Hepatol. 2025;30 Supl 2:102082

Full text access

Share

ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS USING THE PBC-27 QUESTIONNAIRE AT A TERTIARY CARE CENTER

Deborah Espinoza Lopez, Rodrigo Toledo Galvan, Maria Beatriz Jourdan Rodriguez, Viridiana Lopez Ladron de Guevara, Maria de Fatima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102083

Full text access

Share

CORRELATION BETWEEN LI-RADS CLASSIFICATION AND HISTOPATHOLOGICAL FINDINGS IN PATIENTS WITH SUSPECTED HEPATOCELLULAR CARCINOMA

Alonso Vera Torres, Valentina Mejia Valdes, Diana Fernanda Bejarano Ramirez

Ann Hepatol. 2025;30 Supl 2:102084

Full text access

Share

LYSOSOMAL ACID LIPASE ACTIVITY CORRELATES WITH IMMUNE AND BIOCHEMICAL BIOMARKERS METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE BETTER EFFECT ON METABOLIC SYNDROME PATIENTS, PRELIMINARY STUDY

Adriana Martínez Cuazitl, Stefanny Cornejo Hernández, Esly Esquivel Alarcón, Gustavo Jesús Vazquez Zapien, Monica Maribel Mata Miranda, Juan Salvador García Hernandez, Alejandro Gutiérrez Atemis, Reina Hernández Espinosa, Eira Cerda Reyes

Ann Hepatol. 2025;30 Supl 2:102085

Full text access

Share

CLINICAL AND EPIDEMIOLOGICAL CHARACTERIZATION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA

Alonso Vera Torres, Valentina Mejia Valdes, Diana Fernanda Bejarano Ramirez

Ann Hepatol. 2025;30 Supl 2:102086

Full text access

Share

RISK FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS WITH REFRACTORY ASCITES IN A REFERRAL HOSPITAL IN LIMA, PERU"

Javier Díaz Ferrer, Miguel Castro Reynoso, Estefania Liza Baca, Zuly Placido Damian, Laura Tenorio Castillo

Ann Hepatol. 2025;30 Supl 2:102087

Full text access

Share

PRIMARY BILIARY CHOLANGITIS AT A TERTIARY CARE HOSPITAL

Deborah Espinoza Lopez, Rodrigo Toledo Galvan, Maria Beatriz Jourdan Rodriguez, Viridiana Lopez Ladron de Guevara, Maria de Fatima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102088

Full text access

Share

DEMOGRAPHIC, CLINICAL, AND BIOCHEMICAL CHARACTERISTICS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WITH AN UNFAVORABLE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID IN A TERTIARY CARE HOSPITAL

Deborah Espinoza Lopez, Rodrigo Toledo Galvan, Maria Beatriz Jourdan Rodriguez, Viridiana Lopez Ladron de Guevara, Maria de Fatima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102089

Full text access

Share

LIPID PROFILE-RELATED MARKERS AS PREDICTORS OF 28- AND 90-DAY MORTALITY IN PATIENTS WITH ALCOHOL-RELATED DECOMPENSATED CIRRHOSIS (DC) AND ACUTE-ON-CHRONIC LIVER FAILURE (ACLF): FIRST STUDY IN PATIENTS FROM WESTERN MEXICO

Tonatiuh Abimael Baltazar Díaz, Paula Alejandra Castaño Jiménez, Luis Gilberto Huerta Gómez, Ksenia Klimov Kravtchenko, Luz Alicia González Hernández, Kevin Javier Arellano Arteaga, Jesse Haramati, Susana del Toro Arreola, Miriam Ruth Bueno Topete

Ann Hepatol. 2025;30 Supl 2:102090

Full text access

Share

CLINICAL RESULTS IN PATIENTS WITH GASTROESOPHAGEAL VARICEAL BLEEDING IN THE ICU: ANALYSIS OF 85 CASES IN A TERTIARY CARE CENTRE

Francisca Valentina Lazo Sagredo, Bunio Julian Ignacio Weissglas Orellana, Rocío Catalina Cerda Espinoza, Maria José Chazal Contreras, Ignacio José Caro Arias, Juan Pablo Aqueveque Aliquintuy, Diego Alberto San Martín Rodríguez

Ann Hepatol. 2025;30 Supl 2:102091

Full text access

Share

DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, AND DIAGNOSTIC-THERAPEUTIC MANAGEMENT OF PATIENTS WITH CHOLANGIOCARCINOMA AT A TERTIARY CARE CENTER

Deborah Espinoza Lopez, Rodrigo Toledo Galvan, Rocio del Carmen Baltazar Contreras, Maria de Fatima Higuera de la Tijera

Ann Hepatol. 2025;30 Supl 2:102092

Full text access

Share

MICROPLANNING WORKSHOPS: STRUCTURING CARE PATHWAYS AS A STRATEGY FOR VIRAL HEPATITIS ELIMINATION

Carla Francisca Cruz dos Santos, Elton Carlos de Almeida, Jose Nilton Neris Gomes, Ana Paula Maciel Gurski, Ana Mônica de Mello, João Vitor da Mota Silva, Isabelle Cristine de Jesus Macedo, Nathália da Silva Cruz, ... Mario Peribanez Gonzalez

Ann Hepatol. 2025;30 Supl 2:102093

Full text access

Share

OMEGA-5 FATTY ACID NANO AS AN ADJUVANT THAT REDUCES OXIDA-INFLAMMATION IN PATIENTS WITH SEVERE ALCOHOL-ASSOCIATED HEPATITIS

Gabriela Gutiérrez Reyes, Moisés Martínez Castillo, Abigail Hernández Barragán, Adrián Flores Sánchez, Froylan Martínez Sánchez, Marisela Hernandez Santillán, Daniel Santana Vargas, Erik Bojorquez Váldez, Jacqueline Córdova Gallardo

Ann Hepatol. 2025;30 Supl 2:102094

Full text access

Share

LAPAROSCOPIC LIVER RESECTION AS A TREATMENT FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA IN PATIENTS WITH AND WITHOUT PORTAL HYPERTENSION: A CASE-CONTROL STUDY

Álvaro Urzúa Manchego, Deycies Gaete Letelier, Omar Orellana Espinoza, Hans Lembach Jahnsen, Carlos Mandiola Bunster, Jaime Castillo Koch, Juan Carlos Diaz Jeraldo, Alexandre Saure Maritano

Ann Hepatol. 2025;30 Supl 2:102095

Full text access

Share

IGFBPS, MMPS, AND CYTOKINES IN LIVER FIBROSIS: COMPARATIVE NON-INVASIVE BIOMARKER ANALYSIS.

Abigail Hernández Barragán, Gabriela Gutiérrez Reyes, Marisela Hernández Santillan, Moisés Martínez Castillo, Paula Cordero Pérez, Fátima Higuera de la Tijera, Zaira Medina Avila, Linda Muñoz Espinosa, ... Daniel Santana Vargas

Ann Hepatol. 2025;30 Supl 2:102096

Full text access

Share

INFLUENTIAL VARIABLES FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN HIGH-RISK PATIENTS.

Dayron Páez Suárez, Antonio Díaz Machado, Mayra Zoa Más Martínez, Kenia Yusnarkis Valenzuela Aguilera, Mirta Infante Velázquez, Enrique Rogelio Arús Soler

Ann Hepatol. 2025;30 Supl 2:102097

Full text access

Share

DIAGNOSTIC ACCURACY OF NON INVASIVE TESTS FOR FIBROSIS IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE

Fernando Javier Barreyro, Matias Bori, Domingo Balderramo, Maria Del Valle Aubone, Guillermo Fernandez, Omar Soto Oca, Sebastian Paredes, Esteban Gonzalez Ballerga

Ann Hepatol. 2025;30 Supl 2:102098

Full text access

Share

EVALUATION OF METABOLIC FACTORS IN THE DEVELOPMENT OF HEPATOCARCINOMA IN PATIENTS WITH CHRONIC LIVER DISEASE.

Vilma Hernández Garza, Kenia Michel Bastida Guadarrama, Berenice Lorenzo Valle, Jose Luis Perez Hernandez, Maria de Fatima Higuera de la Tijera, Eulalio Gutierrez Rodriguez

Ann Hepatol. 2025;30 Supl 2:102099

Full text access

Share

PROGNOSTIC ABILITY OF DIFFERENT SCORING SYSTEMS TO PREDICT VERY EARLY MORTALITY IN PATIENTS WITH CIRRHOSIS AND ACUTE-ON-CHRONIC LIVER FAILURE (ACLF)

Vilma Hernandez Garza, Kenia Michel Bastida Guadarrama, Jose Luis Perez Hernandez, Maria de Fatima Higuera de la Tijera, Eulalio Gutierrez Rodriguez

Ann Hepatol. 2025;30 Supl 2:102100

Full text access

Share

EVALUATION OF OXIDATIVE STRESS MARKERS IN DISEASES ASSOCIATED WITH ALCOHOL CONSUMPTION.

Kenia Michel Bastida Guadarrama, Vilma Hernández Garza, Abigail Hernández Barragán, Adrián Flores Sánchez, Jessica Mejía Ramírez, Gabriela Gutiérrez Reyes, José Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2:102101

Full text access

Share

COST-EFFECTIVENESS OF L-ORNITHINE L-ASPARTATE THERAPY IN SEVERE HEPATIC ENCEPHALOPATHY

Kenia Michel Bastida Guadarrama, Ángel D. Santana Vargas, Vilma Hernández Garza, Jessica Mejía Ramírez, Fátima Higuera de la Tijera, José Luis Pérez Hernández

Ann Hepatol. 2025;30 Supl 2:102102

Full text access

Share

USEFULNESS OF ALPHA-FETOPROTEIN AND PIVKA-II DETECTION IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN AT-RISK POPULATION

Dayron Páez Suárez, Antonio Díaz Machado, Mayra Zoa Más Martínez, Kenia Yusnarkis Valenzuela Aguilera, Mirta Infante Velázquez, Enrique Rogelio Arús Soler

Ann Hepatol. 2025;30 Supl 2:102103

Full text access

Share